Literature DB >> 15084512

Inflammation underlying cardiovascular mortality is a late consequence of evolutionary programming.

Anita H J Van Den Biggelaar1, Anton J M De Craen, Jacobijn Gussekloo, Tom W J Huizinga, Bastiaan T Heijmans, Marijke Frölich, Tom B L Kirkwood, Rudi G J Westendorp.   

Abstract

With the increase in life expectancy, death from cardiovascular disease has risen greatly. There is increasing evidence that inflammation plays an important role in cardiovascular disease. We postulate that the development of cardiovascular disease in old age is a late consequence of evolutionary programming for a pro-inflammatory response to resist infections in early age. In 311 women, aged 85 yr old, the production of the pro- and anti-inflammatory cytokines tumor necrosis factor (TNF)-alpha and interleukin (IL)-10 was determined in lipopolysaccharide-stimulated whole blood samples and studied prospectively in association with cardiovascular mortality. High TNF-alpha was a risk factor for death from cardiovascular disease (relative risk [RR] = 1.56; 95% confidence interval [CI]: 1-2.40), whereas high IL-10 was protective (RR = 0.58; 95% CI: 0.40-0.85). A genetic variant of the IL-10 gene promoter, which is associated with lower IL-10 production, was found to predispose to a 2.8-fold higher cardiovascular mortality risk (95% CI: 1.17-6.60). Reproductive success, which was studied as a measure of evolutionary programming because it trades off with early survival by pro-inflammatory resistance genes, was negatively associated with an increasing production of TNF-alpha (RR = 0.77; 95% CI: 0.68-0.88), while a positive association with IL-10 was found (RR = 1.22; 95% CI: 1.05-1.41). We suggest that cardiovascular mortality is a late consequence of evolutionary programming for a pro-inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084512     DOI: 10.1096/fj.03-1162fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  12 in total

1.  Commonly studied polymorphisms in inflammatory cytokine genes show only minor effects on mortality and related risk factors in nonagenarians.

Authors:  Serena Dato; Karen S Krabbe; Mikael Thinggaard; Bente K Pedersen; Kaare Christensen; Helle Bruunsgaard; Lene Christiansen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-01-18       Impact factor: 6.053

Review 2.  Are toll-like receptors potential drug targets for atherosclerosis? Evidence from genetic studies to date.

Authors:  Christopher P Nelson; Clett Erridge
Journal:  Immunogenetics       Date:  2018-10-16       Impact factor: 2.846

Review 3.  Evolution of inflammatory diseases.

Authors:  Daniel Okin; Ruslan Medzhitov
Journal:  Curr Biol       Date:  2012-09-11       Impact factor: 10.834

4.  A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease.

Authors:  Virginia Reichert; Xiangying Xue; Diane Bartscherer; Daniel Jacobsen; Christine Fardellone; Patricia Folan; Nina Kohn; Arunabh Talwar; Christine N Metz
Journal:  Chest       Date:  2009-02-18       Impact factor: 9.410

5.  Aging Immune System in Acute Ischemic Stroke: A Transcriptomic Analysis.

Authors:  Gina P Sykes; Joseph Kamtchum-Tatuene; Sarina Falcione; Sarah Zehnder; Danielle Munsterman; Boryana Stamova; Bradley P Ander; Frank R Sharp; Glen Jickling
Journal:  Stroke       Date:  2021-03-01       Impact factor: 7.914

6.  Plasma fibrinogen level: an independent risk factor for long-term survival in Chinese patients with peripheral artery disease?

Authors:  Bernice L Y Cheuk; Grace C Y Cheung; Silvana S F Lau; Stephen W K Cheng
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.282

7.  Is inflammaging an auto[innate]immunity subclinical syndrome?

Authors:  Sergio Giunta
Journal:  Immun Ageing       Date:  2006-12-16       Impact factor: 6.400

8.  Impact of aerobic exercise on levels of IL-4 and IL-10: results from two randomized intervention trials.

Authors:  Shannon M Conroy; Kerry S Courneya; Darren R Brenner; Eileen Shaw; Rachel O'Reilly; Yutaka Yasui; Christy G Woolcott; Christine M Friedenreich
Journal:  Cancer Med       Date:  2016-08-03       Impact factor: 4.452

9.  An Appropriate Modulation of Lymphoproliferative Response and Cytokine Release as Possible Contributors to Longevity.

Authors:  Irene Martínez de Toda; Carmen Vida; Mónica De la Fuente
Journal:  Int J Mol Sci       Date:  2017-07-24       Impact factor: 5.923

Review 10.  Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms.

Authors:  Maria Teresa Ventura; Nicola Scichilone; Roberto Paganelli; Paola Lucia Minciullo; Vincenzo Patella; Matteo Bonini; Giovanni Passalacqua; Carlo Lombardi; Livio Simioni; Erminia Ridolo; Stefano R Del Giacco; Sebastiano Gangemi; Giorgio Walter Canonica
Journal:  Clin Mol Allergy       Date:  2017-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.